Rhea Coler, Phd
Chief Operations Officer
immunology
Immunocellular Therapeutics
Anguilla
Biography
Rhea Coler is the Vice President of Preclinical Biology at IDRI. Her work focuses on the characterization of candidate vaccines for tuberculosis, leishmaniasis, pneumococcus, malaria and chlamydia. Uncovering the roles that innate and adaptive immunity play during these infectious processes are key research questions in the Coler lab. Elucidating the mechanisms of protection against these diseases could lead to the development of novel prophylactic and therapeutic interventions.
Research Interest
Rhea Coler is the Vice President of Preclinical Biology at IDRI. Her work focuses on the characterization of candidate vaccines for tuberculosis, leishmaniasis, pneumococcus, malaria and chlamydia. Uncovering the roles that innate and adaptive immunity play during these infectious processes are key research questions in the Coler lab. Elucidating the mechanisms of protection against these diseases could lead to the development of novel prophylactic and therapeutic interventions.
